Cargando…

Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs

Coronaviruses (CoVs) are positive-stranded RNA viruses that infect humans and animals. Infection by CoVs such as HCoV-229E, -NL63, -OC43 and -HKU1 leads to the common cold, short lasting rhinitis, cough, sore throat and fever. However, CoVs such as Severe Acute Respiratory Syndrome Coronavirus (SARS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neogi, Ujjwal, Hill, Kyle J., Ambikan, Anoop T, Heng, Xiao, Quinn, Thomas P., Byrareddy, Siddappa N., Sönnerborg, Anders, Sarafianos, Stefan G., Singh, Kamal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281371/ https://www.ncbi.nlm.nih.gov/pubmed/32357471 http://dx.doi.org/10.3390/pathogens9050320

Ejemplares similares

Proteomic landscape of astrocytes and pericytes infected with HIV/SARS-CoV-2 mono/co-infection, impacting on neurological complications
por: Acharya, Arpan, et al.
Publicado: (2023)

MiDRMpol: A High-Throughput Multiplexed Amplicon Sequencing Workflow to Quantify HIV-1 Drug Resistance Mutations against Protease, Reverse Transcriptase, and Integrase Inhibitors
por: Aralaguppe, Shambhu G., et al.
Publicado: (2019)

GS-CA Compounds: First-In-Class HIV-1 Capsid Inhibitors Covering Multiple Grounds
por: Singh, Kamal, et al.
Publicado: (2019)

Transcriptomics and Targeted Proteomics Analysis to Gain Insights Into the Immune-control Mechanisms of HIV-1 Infected Elite Controllers
por: Zhang, Wang, et al.
Publicado: (2017)

Genome-scale metabolic models for natural and long-term drug-induced viral control in HIV infection
por: Ambikan, Anoop T, et al.
Publicado: (2022)

Infectivity of SARS-CoV-2: there Is Something More than D614G?
por: Kannan, Saathvik R., et al.
Publicado: (2020)

Distinct lipid profile, low-level inflammation, and increased antioxidant defense signature in HIV-1 elite control status
por: Sperk, Maike, et al.
Publicado: (2021)

Increased acquired protease inhibitor drug resistance mutations in minor HIV-1 quasispecies from infected patients suspected of failing on national second-line therapy in South Africa
por: Obasa, Adetayo Emmanuel, et al.
Publicado: (2021)

Role of myeloid cells in system-level immunometabolic dysregulation during prolonged successful HIV-1 treatment
por: Svensson Akusjärvi, Sara, et al.
Publicado: (2023)

Structural Implications of Genotypic Variations in HIV-1 Integrase From Diverse Subtypes
por: Rogers, Leonard, et al.
Publicado: (2018)

Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: A cross-talk between glycolysis and HIF signaling
por: Akusjärvi, Sara Svensson, et al.
Publicado: (2021)

Evolution, correlation, structural impact and dynamics of emerging SARS-CoV-2 variants
por: Spratt, Austin N., et al.
Publicado: (2021)

Drug Resistance in Non-B Subtype HIV-1: Impact of HIV-1 Reverse Transcriptase Inhibitors
por: Singh, Kamalendra, et al.
Publicado: (2014)

Long-Acting Anti-HIV Drugs Targeting HIV-1 Reverse Transcriptase and Integrase
por: Singh, Kamal, et al.
Publicado: (2019)

In silico and in vitro studies reveal complement system drives coagulation cascade in SARS-CoV-2 pathogenesis
por: Tiwari, Ritudhwaj, et al.
Publicado: (2020)

Peripheral blood CD4(+)CCR6(+) compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals
por: Svensson Akusjärvi, Sara, et al.
Publicado: (2022)

Characterization of Inducible Transcription and Translation-Competent HIV-1 Using the RNAscope ISH Technology at a Single-Cell Resolution
por: Zhang, Wang, et al.
Publicado: (2018)

Combining antiviral drugs with BET inhibitors is beneficial in combatting SARS‐CoV‐2 infection
por: Acharya, Arpan, et al.
Publicado: (2022)

Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells
por: Appelberg, Sofia, et al.
Publicado: (2020)

Whole-Genome Metagenomic Analysis of the Gut Microbiome in HIV-1-Infected Individuals on Antiretroviral Therapy
por: Bai, Xiangning, et al.
Publicado: (2021)

Metabolic Perturbation Associated With COVID-19 Disease Severity and SARS-CoV-2 Replication
por: Krishnan, Shuba, et al.
Publicado: (2021)

Complex Mutation Pattern of Omicron BA.2: Evading Antibodies without Losing Receptor Interactions
por: Kannan, Saathvik R., et al.
Publicado: (2022)

Cell-type-resolved quantitative proteomics map of interferon response against SARS-CoV-2
por: Saccon, Elisa, et al.
Publicado: (2021)

Multi-omics personalized network analyses highlight progressive disruption of central metabolism associated with COVID-19 severity
por: Ambikan, Anoop T., et al.
Publicado: (2022)

Plasma Metabolic Signature and Abnormalities in HIV-Infected Individuals on Long-Term Successful Antiretroviral Therapy
por: Babu, Hemalatha, et al.
Publicado: (2019)

Discovery and Evaluation of Entry Inhibitors for SARS-CoV-2 and Its Emerging Variants
por: Acharya, Arpan, et al.
Publicado: (2021)

Quantitative humoral profiling of the HIV-1 proteome in elite controllers and patients with very long-term efficient antiretroviral therapy
por: Zhang, Wang, et al.
Publicado: (2017)

Altered Gut Microbiome under Antiretroviral Therapy: Impact of Efavirenz and Zidovudine
por: Ray, Shilpa, et al.
Publicado: (2020)

SARS-CoV2 induced respiratory distress: Can cannabinoids be added to anti-viral therapies to reduce lung inflammation?
por: Byrareddy, Siddappa N., et al.
Publicado: (2020)

Temporal Trends in the Swedish HIV-1 Epidemic: Increase in Non-B Subtypes and Recombinant Forms over Three Decades
por: Neogi, Ujjwal, et al.
Publicado: (2014)

Effect of therapy switch on time to second-line antiretroviral treatment failure in HIV-infected patients
por: Häggblom, Amanda, et al.
Publicado: (2017)

Long-Term Efficacy of First Line Antiretroviral Therapy in Indian HIV-1 Infected Patients: A Longitudinal Cohort Study
por: Neogi, Ujjwal, et al.
Publicado: (2013)

Recent increased identification and transmission of HIV-1 unique recombinant forms in Sweden
por: Neogi, Ujjwal, et al.
Publicado: (2017)

Cytotoxic Lymphocytes Target HIV-1 Gag Through Granzyme M-Mediated Cleavage
por: Saccon, Elisa, et al.
Publicado: (2021)

Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies
por: Kannan, Saathvik R., et al.
Publicado: (2022)

Immune landscape of female reproductive tract and HIV susceptibility
por: Byrareddy, Siddappa N.
Publicado: (2021)

Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses
por: Kannan, Saathvik R., et al.
Publicado: (2021)

Human APOBEC3G-mediated hypermutation is associated with antiretroviral therapy failure in HIV-1 subtype C-infected individuals
por: Neogi, Ujjwal, et al.
Publicado: (2013)

SARS-CoV-2 Infection Leads to Neurological Dysfunction
por: Acharya, Arpan, et al.
Publicado: (2020)

Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy
por: Svärd, Jenny, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ar0abi978qnfrnc5ujof6n7dl5